People · Operator
Named in public records as an officer, director or promoter · active 2020–2024 · Healthtech, Other Technology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NoHo Dental , Inc. | — | Healthtech | Series D+ | $268.6M | $741.7M | 2021 |
| Nectar Life Sciences, Inc. | — | Other Technology | Series B | $24.3M | $320.5M | 2022 |
| Dayforward Inc. | — | Other | Series B | $20.0M | $326.1M | 2020 |
Patrick Chun at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Patrick Chun on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jed Cairo | 2 | 3 |
| Lee Fixel | 1 | 20 |
| James Joaquin | 1 | 10 |
| Ryan Johnson | 1 | 9 |
| Annie Kadavy | 1 | 5 |
| Benjamin Robbins | 1 | 5 |
| Aaron Shapiro | 1 | 4 |
| Larson Douglas Hudson | 1 | 3 |
| Roshni Chandwani | 1 | 2 |
| Mark Lotke | 1 | 2 |
| John Lyman | 1 | 2 |
| Brian Bouma | 1 | 2 |
| Paul Rooney | 1 | 1 |
| Troy Bage | 1 | 1 |
| Charles Talbot | 1 | 1 |
| Larson Hudson | 1 | 1 |
| John Douglas Lyman | 1 | 1 |
| Annie Douglas Kadavy | 1 | 1 |
| Patrick Douglas Chun | 1 | 1 |
| Jed Douglas Cairo | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.